These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6456219)

  • 41. Cross-resistance between some aminoglycoside antibiotics.
    Onaolapo JA
    Afr J Med Med Sci; 1994 Sep; 23(3):215-9. PubMed ID: 7604744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
    Lang SD; Durack DT
    Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
    [No Abstract]   [Full Text] [Related]  

  • 44. [Routine test for sensitivity (author's transl)].
    Wiedemann B
    Immun Infekt; 1978 Dec; 6(6):209-13. PubMed ID: 103803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
    Langmaack H; Daschner F
    Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Pot CM; Westerdaal NA
    J Antimicrob Chemother; 1981 Aug; 8(2):101-6. PubMed ID: 6456254
    [No Abstract]   [Full Text] [Related]  

  • 48. [Structure-activity relationship of cephalosporins. II. Effect of oxygen-containing functional groups on the biological activity od cephalosporins--derivatives of 7-aminocephalosporanic acid].
    Grabarnik MS; Iakhkind MI; Znamenskiĭ IuV; Kocherezhko NA
    Antibiot Khimioter; 1991 Apr; 36(4):12-5. PubMed ID: 1909856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anomalous effect of serum on the antimicrobial activity of cefoperazone.
    Lang SD; Cameron GL; Mullins PR
    Drugs; 1981; 22 Suppl 1():52-9. PubMed ID: 6456892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative susceptibility patterns of common clinical isolates to cefoperazone: 1981 to 1987.
    Jenkins SG
    Am J Med; 1988 Jul; 85(1A):52-5. PubMed ID: 3135749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of third generation cephalosporins against Pseudomonas aeruginosa in high risk hospital units.
    Puri J; Revathi G; Kundra P; Talwar V
    Indian J Med Sci; 1996 Jul; 50(7):239-43. PubMed ID: 8979542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum bactericidal activity of cefoperazone and ceftazidime at increasing dosages against Pseudomonas aeruginosa.
    Van Laethem Y; Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1983 Nov; 12(5):475-80. PubMed ID: 6423611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms.
    Hong J; Hu J; Ke F
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6067-75. PubMed ID: 27480861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical studies of cefoperazone in the treatment of pyoderma (author's transl)].
    Gondo A; Kimura K; Tokuda Y
    Jpn J Antibiot; 1980 Dec; 33(12):1306-12. PubMed ID: 6454014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.
    Funk EA; Strausbaugh LJ
    Pharmacotherapy; 1982; 2(4):185-96. PubMed ID: 6221236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.
    Fass RJ
    Antimicrob Agents Chemother; 1980 Sep; 18(3):483-6. PubMed ID: 6448581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibacterial action of cefoperazone and piperacillin against Escherichia coli].
    Obana Y; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Feb; 36(2):249-59. PubMed ID: 6222209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].
    Ratschow R; Krone JR
    Infection; 1977; 5(4):236-41. PubMed ID: 340385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of antimicrobial resistance in bacteria.
    Tenover FC
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S3-10; discussion S64-73. PubMed ID: 16813980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.